Back to Results
First PageMeta Content
Clinical research / Research / Pharmaceuticals policy / Drug discovery / Pharmacovigilance / Regulatory requirement / Food and Drug Administration / Clinical trial / Good Clinical Practice / Pharmaceutical sciences / Pharmacology / Pharmaceutical industry


Microsoft PowerPoint - k-2- Risk Management.ppt
Add to Reading List

Document Date: 2012-06-22 04:07:06

Open Document

File Size: 129,52 KB

Share Result on Facebook

City

BANGKOK / /

Company

CSO Novartis (Thailand) Limited / Novartis / Risk Management / Risk Management Systems / /

Country

Australia / United States / Canada / /

Event

FDA Phase / /

MedicalCondition

torsade de pointes / Dofetilide Minimize arrhythmia / Objectives Drug Goal Objective Clozapine No agranulocytosis WBC / Preventable Adverse Events Injury / /

Organization

FDA / European Union / /

Person

Judith Sills / Sudhichai Chokekijchai / /

Position

Global Head / /

Product

Clozapine / Lindane / For Drug / OF DRUG / /

Technology

DRUG DEVELOPMENT / /

SocialTag